LI Ming
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaQIAO Chenhui
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaZHANG Weihua
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaWU Tiejun
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaWANG Zhibin
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaWEN Meng
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaLIU Yang
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaFAN Kaikai
Department of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, ChinaDepartment of Cardiovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China)
R363;R5
LI Ming, QIAO Chenhui, ZHANG Weihua, WU Tiejun, WANG Zhibin, WEN Meng, LIU Yang, FAN Kaikai. MiR-301 improves cardiomyocyte apoptosis in rats with coronary heart disease by activating Wnt/β-catenin signaling pathway[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(11):949-954.
Copy